CM Management, LLC
Long book
$119.6M
Q1 2026
Positions
71
Top-10 weight
39%
concentration
Last quarter
+24.3%
SPY +14.8%
Turnover
34%
of book per quarter
Strategy in plain words
auto-generated from filingsCM Management, LLC is a diversified fundamental manager, running a $119.6M US long book across 71 positions.
The portfolio is moderately concentrated (top 10 ≈ 39% of the book). The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: ALICO INC, RIGEL PHARMACEUTICALS INC, ROYALTY PHARMA PLC- CL A, RADIANT LOGISTICS INC, INTEST CORP.
Over the last 9 quarters its long book ran on average 0.5pp per quarter ahead of the S&P 500, beating the index in 4 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-7.0%
Q2 2024
+10.2%
Q3 2024
-2.3%
Q4 2024
-5.2%
Q1 2025
+2.3%
Q2 2025
+15.7%
Q3 2025
+2.2%
Q4 2025
+4.6%
Q1 2026
+24.3%
Sector allocation
Healthcare 39%
Financials 14%
Industrials 12%
Technology 11%
Consumer discretionary 8%
Consumer staples 8%
Real estate 2%
Other 2%
Long book by quarter
What does CM Management, own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| ALCO ALICO INC | Consumer staples | 200.0K | $8.3M | 6.9% | Held |
| RIGL RIGEL PHARMACEUTICALS INC | Healthcare | 235.0K | $6.4M | 5.3% | +4.4% |
| RPRX ROYALTY PHARMA PLC- CL A | Healthcare | 125.0K | $6.0M | 5.0% | +66.7% |
| RLGT RADIANT LOGISTICS INC | Industrials | 650.0K | $4.6M | 3.8% | Held |
| INTT INTEST CORP | Technology | 330.0K | $4.5M | 3.8% | -21.0% |
| BGC BGC GROUP INC-A | Financials | 450.0K | $4.4M | 3.7% | +12.5% |
| CHRS COHERUS ONCOLOGY INC | Healthcare | 2.1M | $3.5M | 3.0% | Held |
| CRL CHARLES RIVER LABORATORIES | Healthcare | 17.5K | $3.0M | 2.5% | New |
| HZO MARINEMAX INC | Consumer discretionary | 110.0K | $3.0M | 2.5% | +10.0% |
| NMRK NEWMARK GROUP INC-CLASS A | Real estate | 190.0K | $2.8M | 2.4% | Held |
| OGN ORGANON & CO | Healthcare | 400.0K | $2.4M | 2.0% | +100.0% |
| VTRS VIATRIS INC | Healthcare | 175.0K | $2.4M | 2.0% | -12.5% |
| RBCAA REPUBLIC BANCORP INC-CLASS A | Financials | 32.0K | $2.3M | 1.9% | Held |
| ARKO ARKO CORP | Consumer discretionary | 375.0K | $2.1M | 1.7% | -6.3% |
| ELDN ELEDON PHARMACEUTICALS INC | Healthcare | 650.0K | $2.0M | 1.7% | Held |
| EG EVEREST GROUP LTD | Financials | 6.0K | $2.0M | 1.6% | New |
| AVIR ATEA PHARMACEUTICALS INC | Healthcare | 355.0K | $1.9M | 1.6% | Held |
| THFF FIRST FINANCIAL CORP | Financials | 30.0K | $1.9M | 1.6% | +33.3% |
| VTOL BRISTOW GROUP INC | Industrials | 40.0K | $1.9M | 1.6% | Held |
| ALK ALASKA AIR GROUP INC | Industrials | 50.0K | $1.8M | 1.5% | New |
| IOSP INNOSPEC INC | Materials | 24.0K | $1.8M | 1.5% | +20.0% |
| HPQ HP INC | Technology | 90.0K | $1.7M | 1.4% | New |
| CPA COPA HOLDINGS SA-CLASS A | Industrials | 15.0K | $1.7M | 1.4% | +500.0% |
| EOLS EVOLUS INC | Healthcare | 400.0K | $1.6M | 1.4% | +60.0% |
| IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 450.0K | $1.6M | 1.3% | +12.5% |
| PD PAGERDUTY INC | Technology | 250.0K | $1.6M | 1.3% | +66.7% |
| COYA COYA THERAPEUTICS INC | Healthcare | 375.0K | $1.5M | 1.2% | +7.1% |
| ARKR ARK RESTAURANTS CORP | Consumer discretionary | 225.0K | $1.5M | 1.2% | Held |
| SI SHOULDER INNOVATIONS INC | Healthcare | 100.0K | $1.5M | 1.2% | +300.0% |
| SABR SABRE CORP | Technology | 999.9K | $1.4M | 1.2% | +25.0% |
| CGNT COGNYTE SOFTWARE LTD | Technology | 175.0K | $1.4M | 1.2% | +9.4% |
| CLPT CLEARPOINT NEURO INC | Healthcare | 150.0K | $1.4M | 1.1% | +87.5% |
| ENOV ENOVIS CORP | Healthcare | 60.0K | $1.4M | 1.1% | New |
| VCTR VICTORY CAPITAL HOLDING - A | Financials | 20.0K | $1.3M | 1.1% | New |
| CMCO COLUMBUS MCKINNON CORP/NY | Industrials | 90.0K | $1.3M | 1.1% | +63.6% |
| XOMA XOMA ROYALTY CORPORATION | Healthcare | 40.0K | $1.3M | 1.0% | Held |
| IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 350.0K | $1.2M | 1.0% | New |
| PRU PRUDENTIAL FINANCIAL INC | Financials | 12.5K | $1.2M | 1.0% | New |
| SMG SCOTTS MIRACLE-GRO CO | Other | 20.0K | $1.2M | 1.0% | Held |
| DIT AMCON DISTRIBUTING CO | Consumer discretionary | 13.5K | $1.2M | 1.0% | +50.0% |
| SRCE 1ST SOURCE CORP | Financials | 17.5K | $1.2M | 1.0% | Held |
| BBT BEACON FINANCIAL CORP | Financials | 40.0K | $1.2M | 1.0% | -17.2% |
| PROF PROFOUND MEDICAL CORP | Healthcare | 175.0K | $1.1M | 0.9% | +118.8% |
| MSFT MICROSOFT CORP | Technology | 3.0K | $1.1M | 0.9% | New |
| AMZN AMAZON.COM INC | Consumer discretionary | 5.0K | $1.0M | 0.9% | New |
| HELE HELEN OF TROY LTD | Industrials | 70.0K | $1.0M | 0.8% | +366.7% |
| TNC TENNANT CO | Industrials | 15.0K | $996K | 0.8% | New |
| HRI HERC HOLDINGS INC | Services media | 10.0K | $996K | 0.8% | New |
| CHDN CHURCHILL DOWNS INC | Services media | 10.0K | $898K | 0.8% | New |
| CTSO CYTOSORBENTS CORP | Healthcare | 1.5M | $836K | 0.7% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 8, 2026 | 71 | $119.6M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 2, 2026 | 62 | $118.6M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 13, 2025 | 66 | $119.9M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 12, 2025 | 68 | $109.8M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 9, 2025 | 55 | $99.5M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 7, 2025 | 58 | $112.0M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 12, 2024 | 65 | $125.3M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 1, 2024 | 64 | $109.0M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 70 | $119.1M | canonical | SEC ↗ |
Similar funds
DIAMANT ASSET MANAGEMENT, INC. LILLY ENDOWMENT INCBROOKFIELD Corp /ON/GQG Partners LLCMITSUBISHI UFJ FINANCIAL GROUP INCNewport Trust Company, LLCVIKING GLOBAL INVESTORS LPPARNASSUS INVESTMENTS, LLC MASTERCARD FOUNDATION ASSET MANAGEMENT CORPPZENA INVESTMENT MANAGEMENT LLCCOATUE MANAGEMENT LLCWinslow Capital Management, LLC